Eli Lilly and Novo Nordisk are fighting to capture the weight-loss drug market. Amazon could complicate things.
After winning the battle for injectable obesity medicines, Lilly hopes Foundayo can help it catch up in the oral market, ...
Hosted on MSN
The GLP-1 pill battle just got more interesting
In a direct challenge to the booming obesity-drug business, telehealth company Hims & Hers has rolled out what it says is the cheapest GLP-1 weight-loss pill in the US—and it's already rattling Wall ...
Not a subscriber? Sign up here to get this newsletter in your inbox. In today’s issue: Good afternoon, and welcome to the Health Brief newsletter. It’s April Fools and the only prank I pulled was ...
As more pharmaceutical companies put their hats in the GLP-1 race, with names such as Pfizer, Zealand Pharma, and Amgen due ...
There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...
Dietitian-designed, high-protein meals start at $8.99/serving — the most affordable dedicated GLP-1 meal delivery option without a weekly subscription. A November 2025 KFF poll found that one in eight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results